Latest news

Foresight invests £2m in buy-out at contract research firm

6th August 2018

Epistem, a Manchester-based contract research organisation, has received a £2m investment from Foresight Group to support its management buy-out from genedrive plc.  Dow Schofield Watts Transaction Services advised on the deal. The buy-out was led by Dr Catherine Booth, one of the original founders of Epistem and expert in epithelial stem cell biology, who will be supported by a strong executive team.  … Continued

Read more

This website uses cookies for functionality and allow us to analyse the use of the site. To opt out please view our Cookie Policy. If you continue to browse the site, we'll assume you agree to the use of cookies. [ Hide Notice ]